StockData
Benitec Biopharma Inc. logo

Benitec Biopharma Inc. (BNTC) income statement

BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$7.92−0.23 (-2.76%)

Close on Nov 20, 2026Market cap $276.10MP/E –Yield –

See a number that looks wrong?